SPRUCE BIOSCIENCES, INC. (SPRB) Form 10-K Annual Reports
SPRUCE BIOSCIENCES, INC. (SPRB) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SPRB
CIK: 1683553
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerChristopher Farthing
Audit LocationSan Jose, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0000947871-26-000803 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097316 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-14 | — | SCHEDULE 13G/A Filing | 0001104659-26-097149 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-14 | — | SCHEDULE 13G Filing | 0001535264-26-000044 | View SEC Doc Filr Page |
| 10-Q | 2026-08-12 | 2026-06-30 | 10-Q | 0001193125-26-345876 | View SEC Doc Filr Page |
| 8-K | 2026-08-12 | 2026-08-12 | 8-K | 0001193125-26-345874 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-08-04 | — | SCHEDULE 13G/A Filing | 0001104659-26-090581 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-30 | — | SCHEDULE 13G Filing | 0002012383-26-003098 | View SEC Doc Filr Page |
| 4 | 2026-07-29 | 2026-07-27 | 4 Filing | 0001910132-26-000007 | View SEC Doc Filr Page |
| 3 | 2026-07-29 | 2026-07-27 | 3 Filing | 0001910132-26-000006 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-27 | — | SCHEDULE 13G Filing | 0001493152-26-034786 | View SEC Doc Filr Page |
| 8-K | 2026-07-27 | 2026-07-27 | 8-K | 0001193125-26-316928 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-06-30 | 4 Filing | 0001903669-26-000006 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0001238403-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0001822557-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0001240122-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0001978654-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-05-26 | 2026-05-21 | 4 Filing | 0002051489-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-05-26 | 2026-05-21 | 8-K | 0001193125-26-239230 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001104659-26-062745 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0001172661-26-002385 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0002050709-26-000016 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-05-15 | — | SCHEDULE 13G/A Filing | 0000902219-26-000156 | View SEC Doc Filr Page |
| S-8 | 2026-05-13 | — | S-8 | 0001193125-26-221651 | View SEC Doc Filr Page |
| 10-Q | 2026-05-13 | 2026-03-31 | 10-Q | 0001193125-26-221605 | View SEC Doc Filr Page |